XML 51 R35.htm IDEA: XBRL DOCUMENT v3.5.0.2
LICENSE AGREEMENTS (Details Textual)
1 Months Ended 6 Months Ended
Aug. 05, 2016
USD ($)
Oct. 08, 2014
USD ($)
Feb. 27, 2015
USD ($)
Dec. 27, 2013
USD ($)
Jun. 30, 2016
USD ($)
shares
Jun. 30, 2016
EUR (€)
shares
LICENSE AGREEMENTS [Line Items]            
Additional Milestone Payments to be Received Contingent upon Exercise of Options       $ 325,000,000    
Payments for Royalties | €           € 20,000
Medtronic [Member]            
LICENSE AGREEMENTS [Line Items]            
Upfront Payment   $ 100,000        
Additional Milestone Payable Maximum Amount   $ 7,000,000        
Exosomes License Agreement [Member]            
LICENSE AGREEMENTS [Line Items]            
Upfront Payment     $ 20,000      
Additional Milestone Payable Maximum Amount     190,000      
Reimbursed Expenses to be Paid     34,000      
Janssen Agreement [Member]            
LICENSE AGREEMENTS [Line Items]            
Payment Received For Development Fee       $ 12,500,000    
Minimum [Member]            
LICENSE AGREEMENTS [Line Items]            
Development Milestones         $ 350,000  
Maximum [Member]            
LICENSE AGREEMENTS [Line Items]            
Development Milestones         800,000  
Maximum [Member] | JHU License Agreement [Member]            
LICENSE AGREEMENTS [Line Items]            
Potential Milestone Payments         1,850,000  
Completion of Phase One [Member] | Exosomes License Agreement [Member]            
LICENSE AGREEMENTS [Line Items]            
Milestone Payments To Be Made Upon Successful Completion Of Certain Phases     15,000      
Completion of Phase One [Member] | Minimum [Member]            
LICENSE AGREEMENTS [Line Items]            
Range of Milestone Payments, Payable Upon Successful Completion of Certain Phases         100,000  
Obtention of FDA Approval [Member] | Exosomes License Agreement [Member]            
LICENSE AGREEMENTS [Line Items]            
Milestone Payments To Be Made Upon Successful Completion Of Certain Phases     $ 75,000      
Obtention of FDA Approval [Member] | Maximum [Member]            
LICENSE AGREEMENTS [Line Items]            
Range of Milestone Payments, Payable Upon Successful Completion of Certain Phases         $ 1,000,000  
Subsequent Event [Member] | CSMC [Member]            
LICENSE AGREEMENTS [Line Items]            
Upfront Payment $ 2,500          
Reimbursed Expenses to be Paid 16,000          
Subsequent Event [Member] | CSMC Licence Agreement [Member]            
LICENSE AGREEMENTS [Line Items]            
Upfront Payment 2,500          
Reimbursed Expenses to be Paid $ 10,000          
Mayo License Agreement [Member]            
LICENSE AGREEMENTS [Line Items]            
Common Stock Issued as Additional Consideration for Grant of Certain Rights | shares         18,000 18,000
First and Second Anniversary [Member]            
LICENSE AGREEMENTS [Line Items]            
Payments for Royalties         $ 5,000  
Tenth Anniversary and Thereafter [Member]            
LICENSE AGREEMENTS [Line Items]            
Payments for Royalties         $ 20,000